Furthermore, BOP1 protein expression in situ was also downregulated in the ASMCs of AD patients (n = 28) compared to donors (n = 14) and largely localized to the nucleus (Figures 1(c) and 1(d)). The gene discussed is BOP1; the disease is Alzheimer disease.